Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

TSE:CRDL Stock Latest News

RatingsCardiol Therapeutics: Buy Rating Reiterated as MAVERIC Redesign Strengthens Regulatory Path and 12-Month $10 Price Target Remains Unchanged3d agoCRDL

Company AnnouncementsCardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone1M ago6K CRDL
The FlyCardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial1M agoCRDL
Company AnnouncementsCardiol Therapeutics Bolsters Cash Runway with $7 Million Warrant Exercise Ahead of Phase III Data1M agoCRDL
The FlyCardiol Therapeutics receives over $7M in proceeds from warrant exercise1M agoCRDL

Cardiol Therapeutics Bolsters Governance With Updated Code of Conduct Filing

Company AnnouncementsCardiol Therapeutics Bolsters Governance With Updated Code of Conduct Filing1M ago6K CRDL

Company AnnouncementsCardiol Therapeutics Details Long-Term Manufacturing and Development Agreements in September SEC Filing1M ago6K CRDL

Company AnnouncementsCardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review1M ago6K CRDL

The FlyCardiol Therapeutics files $150M preliminary base shelf prospectus1M agoCRDL
Company AnnouncementsCardiol Therapeutics to Showcase Cardiac Drug Pipeline at H.C. Wainwright Conference1M agoCRDL
The FlyCardiol Therapeutics initiated with a Buy at B. Riley2M agoCRDL
The FlyCardiol Therapeutics price target raised to $10 from $8 at Canaccord2M agoCRDL

Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results

Company AnnouncementsCardiol Therapeutics Reports Second-Quarter 2026 Interim Results2M ago6K CRDL

RatingsEdward Nash Reaffirms Buy on Cardiol with Unchanged $8 Price Target, Citing Strong MAVERIC Trial Design and Attractive CardiolRx Commercial Prospects2M agoCRDL

Company AnnouncementsCardiol Therapeutics to Present Heart Disease Pipeline at Canaccord Genuity Growth Conference2M ago6K CRDL

Company AnnouncementsCardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial3M ago6K CRDL
The FlyCardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial3M agoCRDL
Company AnnouncementsCardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit3M ago6K CRDL
Company AnnouncementsCardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM4M ago6K CRDL

Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance

Company AnnouncementsCardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance4M ago6K CRDL

Company AnnouncementsCardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials5M ago6K CRDL

Company AnnouncementsCardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ5M ago6K CRDL